JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $418,396 | +66.7% | 226,160 | 0.0% | 0.00% | – |
| Q4 2022 | $251,038 | -55.9% | 226,160 | -6.8% | 0.00% | – |
| Q3 2022 | $569,000 | -22.7% | 242,759 | -0.0% | 0.00% | – |
| Q2 2022 | $736,000 | -60.9% | 242,875 | -12.4% | 0.00% | -100.0% |
| Q1 2022 | $1,883,000 | +56.9% | 277,288 | +93.0% | 0.00% | – |
| Q4 2021 | $1,200,000 | +12.5% | 143,678 | +0.1% | 0.00% | – |
| Q3 2021 | $1,067,000 | -39.2% | 143,585 | -44.4% | 0.00% | -100.0% |
| Q2 2021 | $1,756,000 | -14.5% | 258,092 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $2,055,000 | +15.3% | 200,023 | -21.4% | 0.00% | 0.0% |
| Q4 2020 | $1,782,000 | -29.4% | 254,523 | -17.7% | 0.00% | 0.0% |
| Q3 2020 | $2,525,000 | +28.7% | 309,384 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $1,962,000 | +77.1% | 284,319 | +22.0% | 0.00% | 0.0% |
| Q1 2020 | $1,108,000 | -35.5% | 233,085 | +18.5% | 0.00% | 0.0% |
| Q4 2019 | $1,718,000 | +411.3% | 196,738 | +95.4% | 0.00% | – |
| Q3 2019 | $336,000 | -29.3% | 100,687 | +4.9% | 0.00% | – |
| Q2 2019 | $475,000 | -19.2% | 95,952 | +1.3% | 0.00% | – |
| Q1 2019 | $588,000 | +106.3% | 94,743 | +12.2% | 0.00% | – |
| Q4 2018 | $285,000 | -42.3% | 84,418 | +11.2% | 0.00% | – |
| Q3 2018 | $494,000 | +34.2% | 75,894 | +58.3% | 0.00% | – |
| Q2 2018 | $368,000 | -58.7% | 47,951 | +20.3% | 0.00% | -100.0% |
| Q1 2018 | $891,000 | +64.1% | 39,848 | -6.3% | 0.00% | – |
| Q4 2017 | $543,000 | -15.9% | 42,529 | +2.6% | 0.00% | -100.0% |
| Q3 2017 | $646,000 | +90.0% | 41,437 | +71.1% | 0.00% | – |
| Q2 2017 | $340,000 | +24.5% | 24,219 | +95.5% | 0.00% | – |
| Q1 2017 | $273,000 | – | 12,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |